The acquisition includes a rare immunology disease medicine, Ayvakit/Ayvakyt (avapritinib), approved in the US and the EU, and a promising advanced and early-stage immunology pipeline. Furthermore, ...

The Florida Division of Emergency Management held a press conference on Saturday, urging Floridians to make their final ...

An Oval Office news conference signaled an end to a remarkable period of upheaval across the federal bureaucracy, supervised ...

Tesla CEO Musk said Wednesday evening that he was ending his time as a special government employee. Relations with the Trump ...

Donald Trump and Elon Musk met for a final joint press conference as the Tesla CEO's time at the White House came to an end ...